Crossmark

Inhibition of DPP4 activity in humans establishes its in vivo role in CXCL10 post‐translational modification: prospective placebo‐controlled clinical studies

Crossref DOI link: https://doi.org/10.15252/emmm.201506145

Published Online: 2016-04-14

Published Print: 2016-06-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Decalf, Jérémie

Tarbell, Kristin V

Casrouge, Armanda

Price, Jeffrey D

Linder, Grace

Mottez, Estelle

Sultanik, Philippe

Mallet, Vincent

Pol, Stanislas

Duffy, Darragh https://orcid.org/0000-0002-8875-2308
Albert, Matthew L
Funding

Funding for this research was provided by:

Agence nationale de recherches sur le sida et les hépatites virales

Ligue nationale contre le cancer

National Institute of Diabetes and Digestive and Kidney Diseases
License Information

Text and Data Mining valid from 2016-04-14

Version of Record valid from 2016-04-14
More Information

Article History

Received: 14 December 2015

Revised: 19 February 2016

Accepted: 16 March 2016

First Online: 14 April 2016

Conflict of interest

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below